Laboratory parameters related to monitoring in patients with ulcerative colitis treated with tofacitinib for up to 3 years in the OCTAVE open-label, long-term extension study

Gil Y. Melmed  1     Shannon Chang  2     nicole kulisek  3     Haiyun Fan  3     Nervin Lawendy  3     Eric Maller  3     Arif Soonasra  3     Peter Irving  4    
1 Cedars-Sinai Medical Center,Los Angeles,United States
2 New York University, Langone Health,New York,United States
3 Pfizer Inc,Collegeville,United States
4 Guy’s and St Thomas’ Hos

IBD I (Posters)

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing